Atypical Hemolytic Uremic Syndrome (aHUS) Latest Advances

Complement-coagulation crosstalk in immunothrombosis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 30, 2026

Hematological diseases caused by excessive complement activation

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 30, 2026

Renal-Limited Thrombotic Microangiopathy in Infants: A Case Series.

Journal: Kidney medicine

Published: July 30, 2026

Atypical Hemolytic Uremic Syndrome Associated With Malignant Hypertension Presenting With Pulmonary-Renal Syndrome-like Symptoms.

Journal: Kidney medicine

Published: July 19, 2026

Early Donor-Derived Cell-Free DNA Kinetics After Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Preliminary Observational Study.

Journal: International journal of molecular sciences

Published: July 17, 2026

Complement System Inhibitors in Nephrology: A Comprehensive Review.

Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia

Published: July 09, 2026

Atypical hemolytic uremic syndrome: key points in differential diagnosis and recent advances in treatment

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: July 08, 2026

Atypical Hemolytic Uremic Syndrome With Hypocellular Bone Marrow: A Report of a Rare Case.

Journal: Cureus

Published: June 28, 2026

Postpartum Atypical Hemolytic Uremic Syndrome Complicating β-Thalassemia Intermedia: A Case Report and Literature Review.

Journal: Journal of clinical medicine

Published: June 22, 2026

Hockman A, Anuskiewicz S, Brennan E, et al. Efficacy of eculizumab discontinuation in atypical hemolytic uremic syndrome: a systematic review and meta-analysis. Blood Adv. 2025;9(23):6096-6107.

Journal: Blood advances

Published: June 12, 2026

Ravulizumab administration for relapse prevention in atypical hemolytic uremic syndrome with a CFH variant: A case report.

Journal: Internal medicine (Tokyo, Japan)

Published: June 10, 2026

Influenza A-Associated Thrombotic Microangiopathy With Normal a Disintegrin and Metalloproteinase With Thrombospondin Type 1 Motif 13 (ADAMTS13) in a Young Male Patient: A Case Report.

Journal: Cureus

Published: June 07, 2026

Atypical Hemolytic Uremic Syndrome (aHUS) Latest Advances

Find the Latest Research About Atypical Hemolytic Uremic Syndrome (aHUS)

Complement-coagulation crosstalk in immunothrombosis

Complement-coagulation crosstalk in immunothrombosis

Hematological diseases caused by excessive complement activation

Hematological diseases caused by excessive complement activation

Renal-Limited Thrombotic Microangiopathy in Infants: A Case Series.

Renal-Limited Thrombotic Microangiopathy in Infants: A Case Series.

Atypical Hemolytic Uremic Syndrome Associated With Malignant Hypertension Presenting With Pulmonary-Renal Syndrome-like Symptoms.

Atypical Hemolytic Uremic Syndrome Associated With Malignant Hypertension Presenting With Pulmonary-Renal Syndrome-like Symptoms.

Early Donor-Derived Cell-Free DNA Kinetics After Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Preliminary Observational Study.

Early Donor-Derived Cell-Free DNA Kinetics After Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Preliminary Observational Study.

Complement System Inhibitors in Nephrology: A Comprehensive Review.

Complement System Inhibitors in Nephrology: A Comprehensive Review.

Atypical hemolytic uremic syndrome: key points in differential diagnosis and recent advances in treatment

Atypical hemolytic uremic syndrome: key points in differential diagnosis and recent advances in treatment

Atypical Hemolytic Uremic Syndrome With Hypocellular Bone Marrow: A Report of a Rare Case.

Atypical Hemolytic Uremic Syndrome With Hypocellular Bone Marrow: A Report of a Rare Case.

Postpartum Atypical Hemolytic Uremic Syndrome Complicating β-Thalassemia Intermedia: A Case Report and Literature Review.

Postpartum Atypical Hemolytic Uremic Syndrome Complicating β-Thalassemia Intermedia: A Case Report and Literature Review.

Hockman A, Anuskiewicz S, Brennan E, et al. Efficacy of eculizumab discontinuation in atypical hemolytic uremic syndrome: a systematic review and meta-analysis. Blood Adv. 2025;9(23):6096-6107.

Hockman A, Anuskiewicz S, Brennan E, et al. Efficacy of eculizumab discontinuation in atypical hemolytic uremic syndrome: a systematic review and meta-analysis. Blood Adv. 2025;9(23):6096-6107.

Ravulizumab administration for relapse prevention in atypical hemolytic uremic syndrome with a CFH variant: A case report.

Ravulizumab administration for relapse prevention in atypical hemolytic uremic syndrome with a CFH variant: A case report.

Influenza A-Associated Thrombotic Microangiopathy With Normal a Disintegrin and Metalloproteinase With Thrombospondin Type 1 Motif 13 (ADAMTS13) in a Young Male Patient: A Case Report.

Influenza A-Associated Thrombotic Microangiopathy With Normal a Disintegrin and Metalloproteinase With Thrombospondin Type 1 Motif 13 (ADAMTS13) in a Young Male Patient: A Case Report.